Personal tools

Coexpression cluster:C4307

From FANTOM5_SSTAR

Revision as of 16:40, 26 November 2012 by Autoedit (talk | contribs)
Jump to: navigation, search


Full id: C4307_CD14_lymphoma_splenic_appendix_b_myeloma_cord



Phase1 CAGE Peaks

Hg19::chr3:183208298..183208302,-p@chr3:183208298..183208302
-
Hg19::chr3:183273436..183273469,-p2@KLHL6
Hg19::chr3:183273483..183273504,-p1@KLHL6


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data


No results for this coexpression

Enriched Gene Ontology terms on this co-expression cluster<b>Summary:</b> Results for GOStat analysis on co-expressed clusters. Each cluster with promoters mapping to at least two different genes was analysed with GOStat (PMID: 14962934) with default parameter. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br>data


No GOStat results

Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br>disease_data<br>


Cell Type
Ontology termp-valuen
hematopoietic stem cell2.69e-84168
angioblastic mesenchymal cell2.69e-84168
hematopoietic cell2.24e-81177
hematopoietic oligopotent progenitor cell1.04e-79161
hematopoietic multipotent progenitor cell1.04e-79161
leukocyte3.54e-74136
hematopoietic lineage restricted progenitor cell2.23e-65120
nongranular leukocyte5.75e-65115
myeloid cell3.64e-47108
common myeloid progenitor3.64e-47108
myeloid leukocyte1.24e-4072
myeloid lineage restricted progenitor cell1.05e-3666
granulocyte monocyte progenitor cell4.61e-3667
monopoietic cell2.44e-3359
monocyte2.44e-3359
monoblast2.44e-3359
promonocyte2.44e-3359
macrophage dendritic cell progenitor1.81e-3261
defensive cell4.52e-3248
phagocyte4.52e-3248
classical monocyte4.76e-2942
CD14-positive, CD16-negative classical monocyte4.76e-2942
nucleate cell4.69e-2855
lymphocyte1.02e-2753
common lymphoid progenitor1.02e-2753
lymphoid lineage restricted progenitor cell4.86e-2752
lymphocyte of B lineage1.48e-1524
pro-B cell1.48e-1524
mesenchymal cell3.60e-12354
T cell2.22e-1125
pro-T cell2.22e-1125
connective tissue cell5.61e-11361
stuff accumulating cell3.19e-1087
mature alpha-beta T cell4.04e-0918
alpha-beta T cell4.04e-0918
immature T cell4.04e-0918
mature T cell4.04e-0918
immature alpha-beta T cell4.04e-0918
B cell1.10e-0814
motile cell2.80e-07386
Uber Anatomy
Ontology termp-valuen
hematopoietic system2.18e-4598
blood island2.18e-4598
hemolymphoid system3.42e-45108
immune system5.11e-3593
bone marrow4.58e-3176
bone element1.58e-2682
skeletal element1.53e-2190
lateral plate mesoderm2.82e-17203
adult organism3.41e-17114
skeletal system4.39e-17100
blood5.33e-1115
haemolymphatic fluid5.33e-1115
organism substance5.33e-1115
connective tissue9.52e-10371
Disease
Ontology termp-valuen
hematologic cancer4.62e-1451
immune system cancer4.62e-1451
leukemia2.74e-1039
myeloid leukemia1.76e-0731


Overrepresented TFBS (DNA) motifs on this co-expression cluster<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data


Novel motifs



JASPAR motifs

Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}



ENCODE TF ChIP-seq peak enrichment analysis<b>Summary:</b> For each TF and each co-expression cluster, the number of promoters with ENCODE TF ChIP signal was compared with the rest of promoters from the robust set using Fisher's exact test. Clusters with significant ChIP enrichment (q <= 0.05) after Benjamini-Hochberg correction were retained. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br><br>data


(#promoters = Number of promoters in this coexpression cluster that have ChIP signal of the TF)

TF#promotersEnrichmentp-valueq-value
BATF#10538216.23853452820240.004917462407809970.0230034424621189
MEF2A#4205212.4954872730960.008235029478029740.0324942664219415
PBX3#5090214.60967512449610.006056122473217890.0268529920599645
ZEB1#6935211.25895467836260.01010222676646330.0378214246222634



Relative expression of the co-expression cluster<b>Summary:</b>Co-expression clusters are compared against FANTOM5 samples to obtain relative expression. <br><b>Analyst:</b>NA<br><br>link to data source<br> data


This analysis result is provided for C0 - C305 clusters.